JPS6038666B2 - Creatinine measurement reagent - Google Patents

Creatinine measurement reagent

Info

Publication number
JPS6038666B2
JPS6038666B2 JP49015648A JP1564874A JPS6038666B2 JP S6038666 B2 JPS6038666 B2 JP S6038666B2 JP 49015648 A JP49015648 A JP 49015648A JP 1564874 A JP1564874 A JP 1564874A JP S6038666 B2 JPS6038666 B2 JP S6038666B2
Authority
JP
Japan
Prior art keywords
reagent
creatinine
measurement reagent
lauryl sulfate
creatinine measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49015648A
Other languages
Japanese (ja)
Other versions
JPS50110383A (en
Inventor
邦明 徳田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd filed Critical Wako Pure Chemical Industries Ltd
Priority to JP49015648A priority Critical patent/JPS6038666B2/en
Publication of JPS50110383A publication Critical patent/JPS50110383A/ja
Publication of JPS6038666B2 publication Critical patent/JPS6038666B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Description

【発明の詳細な説明】 本発明は、体液中のクレアチニンを、迅速、正確、簡便
に測定する為の試薬セットに関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a reagent set for rapidly, accurately, and simply measuring creatinine in body fluids.

クレアチンは筋肉の常成分で、リン酸と結合して筋収縮
のエネルギー源となり、その代謝産物としてクレアチニ
ンを生ずる。クレアチニンはクレアチンの無水物で、啓
糸球体で渡週され、その後再吸収されることなく尿中に
排他される。従ってクレアチニンの測定は、糸球体の高
度の病変に起因する啓不全、賢炎等の腎疾患、尿毒症な
らびに筋萎縮症などの診断、治寮経過の観察に有用な情
報を提供する。生体試料中のクレアチニンの測定法とし
ては、数種の測定法が発表されているが、いずれも完壁
という状態にはほど遠く、操作が比較的簡単で、感度が
比較的高い等の理由により、クレアチニンの活性メチレ
ン基とアルカリ性ピクリン酸とを縮合させ、生じた縮合
物を比色定量するフオーリン法が唯一の実際的方法とし
て使用されている。
Creatine is a normal component of muscle, and combines with phosphate to become an energy source for muscle contraction, producing creatinine as a metabolite. Creatinine is an anhydrous form of creatine that is absorbed in the glomerulus and then excreted in the urine without being reabsorbed. Therefore, measurement of creatinine provides useful information for diagnosing renal diseases such as glomerular failure and pharyngitis caused by severe glomerular lesions, uremia, and muscular atrophy, and for observing the progress of treatment. Several methods have been published for measuring creatinine in biological samples, but none of them are far from perfect. The only practical method used is the Folin method, in which the active methylene groups of creatinine are condensed with alkaline picric acid and the resulting condensate is determined colorimetrically.

しかしながらこの測定方法は、クレアチニンに特異的な
反応ではなく、他の活性メチレン基含有物質は全てプラ
スの誤差になる。幸いにしてクレアチニンの吸収が最も
長波長側にある為、多くのものは実質的に測定の妨害と
なることはないとされているが、蛋白は、その縮合物が
クレアチニン縮合物と近い位置に吸収があり、しかも血
清中に多量に存在している為、到底このまま測定するこ
とは出来ず、除蛋白を必要とし、操作が煩雑である等の
問題点がある為、正確と迅速さが要求される臨床検査に
於ては、大きな欠点となっていた。本発明者等は鋭意研
究し、アルカリ水溶液よりなる第1試薬とピクリン酸、
ラウリル硫酸塩、ノニオン系界面活性剤を主剤とする第
2試薬とをセットにすることにより、除蛋白を要せず、
安定な、従来の測定法の欠点を一挙に解決した、完壁な
クレアチニン測定用試薬乃至方法を見出し、本発明を完
成した。アルカリ水溶液よりなる第1試薬としては、例
えば、カセイソーダ、カセィカリ等のアルカリ水溶液が
使用される。
However, this measurement method is not a specific reaction to creatinine, and all other active methylene group-containing substances result in positive errors. Fortunately, the absorption of creatinine is on the longest wavelength side, so it is said that many substances do not substantially interfere with measurements, but proteins, whose condensates are located close to creatinine condensates, Since it is absorbed and is present in large amounts in serum, it is impossible to measure it as is, requiring protein removal, and the operation is complicated, so accuracy and speed are required. This was a major drawback in the clinical tests performed. The present inventors conducted extensive research and found that a first reagent consisting of an alkaline aqueous solution and picric acid,
By combining lauryl sulfate and a second reagent whose main ingredients are a nonionic surfactant, protein removal is not required.
We have discovered a complete reagent or method for measuring creatinine that is stable and solves all the shortcomings of conventional measurement methods, and have completed the present invention. As the first reagent made of an alkaline aqueous solution, for example, an alkaline aqueous solution of caustic soda, caustic potash, or the like is used.

第2試薬は、ピクリン酸、ラウリル硫酸塩、及びノニオ
ン系界面活性剤が主剤であり、隆日変化によるカビの発
生を防ぐ為、防腐剤を添加するのが好ましい。
The second reagent contains picric acid, lauryl sulfate, and a nonionic surfactant as main ingredients, and preferably contains a preservative to prevent the formation of mold due to dilution.

ラウリル硫酸のナトリウム又はカリウム等の塩は、蛋白
質と結合し、ピクリン酸との反応を効果的に抑制する働
きがある。ノニオン系界面活性剤は、冬期の保存時又は
測定時に、ラゥリル硫酸塩が沈澱する問題点を解消する
働きをする。カチオン系、アニオン系の界面活性剤では
、ピクリン酸との反応抑制に障害を生じたり、ラウリル
硫酸塩可溶化剤としての効果が悪かったりして、使用に
は不適当である。本発明に使用するノニオン系界面活性
剤としては、水溶性で、酸性又は塩基性で沈澱しないも
のはすべて使用出来る。若千を例示すれば、ポリオキシ
ェチレンラウリルエーテル、ポリオキシエチレンノニル
フエニルエーテル、ポリオキシエチレンソルビタンモノ
ラウレート、ポリエチレングリコールセチルヱーテル等
が挙げられる。経日変化によるカビの発生を防ぐ為の防
腐剤としては、安息香酸、ソルビン酸など通常のものが
支障なく使用される。以上述べた如く、本発明測定試薬
は、除蛋白を要しない為、極めて簡便、そして正確なる
クレアチニンの測定を可能とし、診断及び袷寮医学に貢
献する所極めて大である。
Salts such as sodium or potassium lauryl sulfate bind to proteins and have the function of effectively suppressing the reaction with picric acid. Nonionic surfactants work to solve the problem of precipitation of lauryl sulfate during winter storage or measurement. Cationic and anionic surfactants are unsuitable for use because they cause problems in suppressing the reaction with picric acid and have poor effects as lauryl sulfate solubilizers. As the nonionic surfactant used in the present invention, any surfactant that is water-soluble and does not precipitate under acidic or basic conditions can be used. Examples of these include polyoxyethylene lauryl ether, polyoxyethylene nonylphenyl ether, polyoxyethylene sorbitan monolaurate, polyethylene glycol cetyl ether, and the like. As preservatives to prevent the growth of mold due to aging, common preservatives such as benzoic acid and sorbic acid can be used without any problems. As described above, since the measurement reagent of the present invention does not require protein removal, it is possible to measure creatinine extremely simply and accurately, and it greatly contributes to diagnosis and medicine.

以下に実施例を挙げ、本発明を更に説明する。The present invention will be further explained with reference to Examples below.

実施例中数量を表わす部は、重量部である。実施例 1
(試薬調整の例)カセイソーダを水に溶解し、0.5規
定溶液とする。
In the examples, all parts expressed are parts by weight. Example 1
(Example of reagent preparation) Dissolve caustic soda in water to make a 0.5N solution.

これが第1試薬の例である。ピクリン酸0.2部、ラウ
リル硫酸ナトリウム0.8部、ポリオキシェチレンラウ
リルェーテル0.4部、安息香酸ナトリウム0.1部を
蒸留水に溶解して全量を100部とする。
This is an example of the first reagent. 0.2 part of picric acid, 0.8 part of sodium lauryl sulfate, 0.4 part of polyoxyethylene lauryl ether, and 0.1 part of sodium benzoate are dissolved in distilled water to make a total amount of 100 parts.

これが第2試薬の例である。ラウリル硫酸ナトリウム0
.8部「 ポリオキシェチレンラウリルェーテル0.4
部、安息香酸ナトリウム0.1部を蒸留水に溶解し全量
を10の歌とする。
This is an example of the second reagent. Sodium lauryl sulfate 0
.. Part 8 “Polyoxyethylene lauryl ether 0.4
1 part and 0.1 part of sodium benzoate were dissolved in distilled water to make a total of 10 parts.

これがプランク液の例である。実施例 2(クレアチニ
ン測定法の例) 2本の試験管に同一の血清50メタずつを入れ、一方を
主検用、他方を盲検用とする。
This is an example of Planck's solution. Example 2 (Example of Creatinine Measuring Method) Fifty doses of the same serum are placed in two test tubes, one for the main test and the other for the blind test.

主検用には実施例1の第1試薬2の‘、第2試薬2の‘
を加え、盲検用には第1試薬2の‘、ブランク液2の‘
を加える。25℃で10分間放置した後、盲検用検体を
対照として、吸光度の差を52仇血で求める。
For the main test, the first reagent 2' and the second reagent 2' of Example 1 were used.
For blind testing, add 1st reagent 2' and blank solution 2'.
Add. After standing at 25°C for 10 minutes, the difference in absorbance was determined using the blind sample as a control.

Claims (1)

【特許請求の範囲】[Claims] 1 アルカリ水溶液よりなる第1試薬とピクリン酸、ラ
ウリル硫酸塩、ノニオン系界面活性剤を主剤とする第2
試薬とをセツトにすることを特徴とする、体液中のクレ
アチニンの測定用試薬。
1 A first reagent consisting of an alkaline aqueous solution and a second reagent consisting of picric acid, lauryl sulfate, and a nonionic surfactant as main ingredients.
A reagent for measuring creatinine in body fluids, characterized in that it is a set of reagents.
JP49015648A 1974-02-07 1974-02-07 Creatinine measurement reagent Expired JPS6038666B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP49015648A JPS6038666B2 (en) 1974-02-07 1974-02-07 Creatinine measurement reagent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49015648A JPS6038666B2 (en) 1974-02-07 1974-02-07 Creatinine measurement reagent

Publications (2)

Publication Number Publication Date
JPS50110383A JPS50110383A (en) 1975-08-30
JPS6038666B2 true JPS6038666B2 (en) 1985-09-02

Family

ID=11894526

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49015648A Expired JPS6038666B2 (en) 1974-02-07 1974-02-07 Creatinine measurement reagent

Country Status (1)

Country Link
JP (1) JPS6038666B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818703A (en) * 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4850795A (en) * 1971-10-20 1973-07-17

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4850795A (en) * 1971-10-20 1973-07-17

Also Published As

Publication number Publication date
JPS50110383A (en) 1975-08-30

Similar Documents

Publication Publication Date Title
Goldstein et al. The urine anion gap: a clinically useful index of ammonium excretion
Burch et al. Improved method for measurement of delta-aminolevulinic acid dehydratase activity of human erythrocytes
Eberts et al. A simplified, colorimetric micromethod for xylose in serum or urine, with phloroglucinol.
Schade et al. Bound iron and unsaturated iron-binding capacity of serum; rapid and reliable quantitative determination
Ludwig et al. The anthrone method for the determination of carbohydrates in foods and in oral rinsing
Serjeant et al. A whole blood solubility and centrifugation test for sickle cell hemoglobin: a clinical trial
Van de Vyver et al. Bone lead in dialysis patients
Morris et al. Assay of plasma 25-hydroxy vitamin D
US3472738A (en) Test implement for detecting peroxidase
Miyamoto Use of plasma clearance of iohexol for estimating glomerular filtration rate in cats
MacDonald et al. The rapid quantitation of serum alpha-fetoprotein by two-site micro enzyme immunoassay
US3461036A (en) Test composition,device and method for detecting urea in aqueous fluids
Berry et al. Detection of metabolic disorders: Chromatographic procedures and interpretation of results
JPS6038666B2 (en) Creatinine measurement reagent
US3894843A (en) Determination of serum creatinine
CN102095881A (en) Chemiluminescence quantitative detection kit for free thyroxine
Hultberg et al. Enzyme Immunoassay of ß-Hexosaminidase Isoenzymes in Human Urine and Renal Cortex with Monoclonal Antibodies
Bradbury A simplified method for the estimation of sodium
Polley Colorimetric determination of nitrogen in biological materials
JPH043828B2 (en)
JPH0245827B2 (en) KUREACHININSOKUTEIYOSHAKUSOSEIBUTSU
Hoch et al. The Determination of Iodine in Biologic Material
US4096037A (en) Arginase test
CN109870578A (en) A kind of cystatin C detection kit
Chiamori et al. Determination of calcium in biologic material by the chloranilate method